Elicio Therapeutics, Inc. (ELTX)
10.59
-0.18
(-1.67%)
USD |
NASDAQ |
May 05, 16:00
10.38
-0.21
(-1.98%)
After-Hours: 20:00
Elicio Therapeutics Total Assets (Quarterly) : 25.86M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Aura Biosciences, Inc. | 319.98M |
| ACADIA Pharmaceuticals, Inc. | 1.564B |
| Alnylam Pharmaceuticals, Inc. | 5.130B |
| Savara, Inc. | 253.44M |
| BioMarin Pharmaceutical, Inc. | 8.591B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 24.23M |
| Shareholders Equity (Quarterly) | 1.636M |
| Debt to Equity Ratio | 8.870 |
| Current Ratio | 2.381 |
| Net Debt Paydown Yield | 1.63% |